Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients

AIM: To assess liver fibrosis (LF) in hepatitis C virus (HCV) and alcoholic liver disease (ALD), estimate health outcomes and costs of new noninvasive testing strategies METHODS: A Markov model was developed to simulate LF progression in HCV and ALD for a cohort of 40-year-old men with abnormal leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto, Marcelo, Sampietro-Colom, Laura, Lasalvia, Luis, Mira, Aurea, Jiménez, Wladimiro, Navasa, Miquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423053/
https://www.ncbi.nlm.nih.gov/pubmed/28533673
http://dx.doi.org/10.3748/wjg.v23.i17.3163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423053/
https://www.ncbi.nlm.nih.gov/pubmed/28533673
http://dx.doi.org/10.3748/wjg.v23.i17.3163

Ejemplares similares